




已阅读5页,还剩32页未读, 继续免费阅读
版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领
文档简介
20/03/2008,Dept. of Pharmaceutics,1,Nanotechnology Based Drug Delivery,Dr. Basavaraj K. Nanjwade M.Pharm., Ph.D Associate Professor Department of Pharmaceutics JN Medical College KLE University Belgaum-590010,20/03/2008,Dept. of Pharmaceutics,2,Applications of Nanotechnology,20/03/2008,Dept. of Pharmaceutics,3,Targeted Drug Delivery,20/03/2008,Dept. of Pharmaceutics,4,Nanoparticles for Drug Delivery,Metal-based nanoparticles Lipid-based nanoparticles Polymer-based nanoparticles Biological nanoparticles,20/03/2008,Dept. of Pharmaceutics,5,Nanobiopharmaceuticals,In biopharmaceuticals, in addition to the main technologies covered-liposomal, monoclonal antibody-based, and polymer-based technologies host of newer technologies such as nanoparticles including various nanodimensional entities such as molecular imprinted polymers, metallofullerenes, prodrug delivery, oral, injectable and implantable, pulmonary, and transdermal and transmucosal delivery have come up.,20/03/2008,Dept. of Pharmaceutics,6,Drug Delivery Technology Important to Pharma Industry,Drug delivery formulations involve low cost research compared that for discovery of new molecule, Minimizing the drug use would significantly reduce the effective cost of drug which would give financial relief to the patients,20/03/2008,Dept. of Pharmaceutics,7,Delivery systems increase commercial opportunity by distinguishing a drug from competitive threats posed by “me too” drugs and Novel means of delivery particularly using nano-carriers, can allow branded drugs to be rescued from abyss of generic competition (may be called “resurrection of drug”).,Drug Delivery Technology Important to Pharma Industry,20/03/2008,Dept. of Pharmaceutics,8,SOME SIGNIFICANT ACHIEVEMENTS OF NANODEVICES,Development of one dose a day ciprofloxacin using nanotechnology Tumor targeted taxol delivery using nanoparticles in Phase 2 clinical trial stage Improved ophthalmic delivery formulation using smart hydrogel nanoparticles Oral insulin formulation using nanoparticles carriers. Liposomal based Amphotericin B formulation,20/03/2008,Dept. of Pharmaceutics,9,CHALLENGES,Prevention of drug from biological degradation Effective Targeting Patient Compliance Cost effectiveness Product life extension,20/03/2008,Dept. of Pharmaceutics,10,PRIORITY AREAS,Cancer Nanotechnology (i) Diagnosis using Quantum Dots (ii) Tumor Targeted Delivery (iii) Imaging (iv) Cancer Gene Therapy,20/03/2008,Dept. of Pharmaceutics,11,PRIORITY AREAS,DNA Vaccines for parasitic, bacterial and viral diseases Oral and pulmonary routes for systemic delivery of proteins and peptides Nanotechnology in Tissue Engineering,20/03/2008,Dept. of Pharmaceutics,12,Drug Delivery Carriers,20/03/2008,Dept. of Pharmaceutics,13,Targeting Ligands,20/03/2008,Dept. of Pharmaceutics,14,Liposomes,20/03/2008,Dept. of Pharmaceutics,15,Liposomes,Their exterior lipid bilayer is very chemically reactive, thereby providing a means to conveniently couple “tags” on a covalent basis. Such “tags” can be antibodies, antigens, cell receptors, nucleic acid probes, etc. This provides significant versatility in assay formats (i.e., immunoassay, receptor-based, nucleic acid probe, etc.) possible. With diameters ranging in size from approximately 50 nm to 800 nm, their aqueous core encapsulates up to millions of molecules of signal generating “markers” that can be detected in a variety of different way. A variety of different encapsulants are possible including visually detectable dyes (since the lipid bilayer is transparent), optically and fluorometrically detectable dyes, enzymes, and electroactive compounds. This provides significant versatility in the detection schemes possible.,20/03/2008,Dept. of Pharmaceutics,16,Niosomes,20/03/2008,Dept. of Pharmaceutics,17,Niosomes,Niosomes, non-ionic surfactant vesicles, are widely studied as an alternative to liposomes These vesicles appear to be similar to liposomes in terms of their physical properties They are also prepared in the same way and under a variety of conditions, from unilamellar or multilamellar structures. Niosomes alleviate the disadvantages associated with liposomes, such as chemical instability, variable purity of phospholipids and high cost. They have the potential for controlled and targated drug delivery Niosomes enhanced the penetration of drugs,20/03/2008,Dept. of Pharmaceutics,18,Nanopowder,20/03/2008,Dept. of Pharmaceutics,19,Nanopowder,Nanopowders are powders composed of nanoparticles, that is particles having an average diameter below 50 nanometers (nm). A jar of a true nanopowder when emptied from chest height to toward the floor will disperse into the air before reaching the floor. Most manufacturers of “nanopowders” produce micropowder assemblies of nanoparticles but the powder itself is rarely a nanopowder. Such compounds have two or more different cations (positively charged elements) in their chemical formula. An example of a complex compound is calcium titanate (CaTiO3).,20/03/2008,Dept. of Pharmaceutics,20,Nanocluster,20/03/2008,Dept. of Pharmaceutics,21,Nanocluster,One of the central themes in nanoscience research is to synthesize high quality nanoparticles with precise control over particle size, shape, structure, and composition. For inorganic nanoparticles (e.g. metal and semiconductor), two regimes are of particular interest, that is, nanoclusters in a size range from subnanometer to 2 nm and nanocrystals (typically 2-100 nm).,20/03/2008,Dept. of Pharmaceutics,22,Nanocrystals,20/03/2008,Dept. of Pharmaceutics,23,Nanocrystals,When the size of the material is reduced to less than 100 nanometers, the realm of quantum physics takes over and materials begin to demonstrate entirely new properties. Nano-design of drugs by various techniques like milling, high pressure homogenization, controlled precipitation etc., are explored to produce, drug nanocrystals, nanoparticles, nanoprecipitates, nanosuspensions (which for ease of understanding commonly mentioned as nanocrystals). As decreased size will increase the solubility of drugs hence, this technology is explored to increase oral bioavailability of sparingly water soluble drugs.,20/03/2008,Dept. of Pharmaceutics,24,Micelle,20/03/2008,Dept. of Pharmaceutics,25,Micelle,Micelle is an aggregate of amphipathic molecules in water, with the nonpolar portions in the interior and the polar portions at the exterior surface, exposed to water. Amphiphilic molecules form micelle above a particular concentration which is called as critical micellar concentration (CMC). Micelles are known to have an anisotropic water distribution within their structure, means water concentration decreases from the surface towards the core of the micelle, with a completely hydrophobic (water-excluded) core. Hydrophobic drugs can be encapsulated/solubalized, into inner core. The spatial position of a solubilized drug in a micelle will depend on its polarity, nonpolar molecules will be solubilized in the micellar core, and substances with intermediate polarity will be distributed along the surfactant molecules in certain intermediate positions.,20/03/2008,Dept. of Pharmaceutics,26,Dendrimers,20/03/2008,Dept. of Pharmaceutics,27,Dendrimers,These branched macromolecules are constructed around a simple core unit. Dendrimers have a high degree of molecular uniformity, narrow molecular weight distribution, specific size and shape characteristics, and a highly- functionalized terminal surface. The manufacturing process is a series of repetitive steps starting with a central initiator core. Each subsequent growth step represents a new “generation“ of polymer with a larger molecular diameter, twice the number of reactive surface sites, and approximately double the molecular weight of the preceding generation.,20/03/2008,Dept. of Pharmaceutics,28,Polymeric Nanoparticles,20/03/2008,Dept. of Pharmaceutics,29,Polymeric Nanoparticles,In recent years, biodegradable polymeric nanoparticles have attracted considerable attention as potential drug delivery devices in view of their applications in drug targeting to particular organs/tissues, as carriers of DNA in gene therapy, and in their ability to deliver proteins, peptides and genes through a per oral route of administration.,20/03/2008,Dept. of Pharmaceutics,30,Carbon 60,20/03/2008,Dept. of Pharmaceutics,31,Carbon 60,C60 are spherical molecules about 1nm in diameter, comprising 60 carbon atoms arranged as 20 hexagons and 12 pentagons: the configuration of a football. Hence they find application as NanoPharmaceuticals with large drug payload in their cage like structure. On the other hand with development of various chemical substitutes
温馨提示
- 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
- 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
- 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
- 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
- 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
- 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
- 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
最新文档
- 2025商业店面租赁合同模板
- 2025餐馆转让合同范本
- 2025标准版设备租赁合同补充协议模板
- 文化产业管理核心内容试题及答案
- 临床执业医师考试2025年在考前自我评估的必要性试题及答案
- 激光应用领域考题及答案分享
- 卫生管理相关证书考试特点的试题及答案
- 急救技能在临床执业医师考试的重要性试题及答案
- 复试外国语试题及答案
- 区县医院面试题及答案
- 2025年四川雅安市名山区茗城有限公司招聘笔试参考题库含答案解析
- 2022年湖南省岳阳市华容县小升初语文试卷
- 【北京】《总也倒不了的老屋》名师课件(第二课时)
- 《肺的结构和功能》课件
- 事业单位考试综合基础知识真题及解析
- 贷款免息申请书
- 光伏安装劳务分包合同
- 长期护理保障失能等级评估规范
- 2025年中国建材集团财务有限公司招聘笔试参考题库含答案解析
- 汇流箱工作原理及日常维护培训课件
- GB/T 45120-2024道路车辆48 V供电电压电气要求及试验
评论
0/150
提交评论